Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

The combined profits for the ten drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion). Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself. The great majority of "new" drugs are not new at all but merely variations of older drugs already on the market. Of the 78 drugs approved by the FDA in 2002, only 17 contained new active ingredients, and only seven of these were classified by the FDA as improvements over older drugs. [The] market would collapse virtually overnight if the FDA made approval of new drugs contingent on their being better in some important way than older drugs already on the market. Many medical schools and teaching hospitals set up "technology transfer" offices to ... capitalize on faculty discoveries. Medical school faculty entered into ... lucrative financial arrangements with drug companies, as did their parent institutions. One of the results has been a growing pro-industry bias in medical research—exactly where such bias doesn't belong. The industry ... fought the state of Maine all the way to the US Supreme Court, which in 2003 upheld Maine's right to bargain with drug companies for lower prices. This industry is taking us for a ride, and there will be no real reform without an aroused and determined public to make it happen.

Note: The above book and book review was written by Dr. Marcia Angell, former editor in chief of the prestigious The New England Journal of Medicine. For more reliable information on the health cover-up, click here.

The NHS is seeking at least Ł100m compensation from two drug companies who it alleges "fixed" the price of an ulcer drug in the late 1990s. The allegations relate to the sale and supply of ranitidine between 1997 and 2000. The NHS's Counter Fraud Service [CFS]...is currently investigating similar concerns in regard to around 30 other drugs. As in any case where a drug comes off patent, the NHS expected its price to fall, but this did not happen with ranitidine. The investigation into why this failed to happen has led to the High Court action against Generics, a subsidiary of the German pharmaceutical company Merck, and the British arm of the Indian company Ranbaxy. The CFS estimates that the NHS could have lost out on at least Ł100m, and possibly as much as Ł110m. It has already said it will sue seven companies over the sale of common medicines including warfarin and penicillin-based drugs.

Starting in the early 1900s, hundreds of thousands of American children were warehoused in institutions by state governments. And the federal government did nothing to stop it. The justification? The kids had been labeled feeble-minded, and were put away in conditions that can only be described as unspeakable. A large proportion of the kids who were locked up were not retarded at all. They were simply poor, uneducated kids with no place to go, who ended up in institutions like the Fernald School in Waltham, Mass. The Fernald School, and others like it, was part of a popular American movement in the early 20th century called the Eugenics movement. The idea was to separate people considered to be genetically inferior from the rest of society, to prevent them from reproducing. Eugenics is usually associated with Nazi Germany, but in fact, it started in America. Not only that, it continued here long after Hitler's Germany was in ruins. Few of the attendants [at Fernald] showed any kindness. And ... there was sexual abuse. The place was tailor made for it. The school [also] allowed them to be used as human guinea pigs. In 1994 Senate hearings, it came out that scientists from MIT had been giving radioactive oatmeal to the boys ... in a nutrition study for Quaker Oats. All they knew is that they'd been asked to join a science club. The boys were recruited with special treats [like] extra milk. “But they forgot to mention the milk was radioactive,” says David White-Lief, an attorney who worked on the state task force investigating the science club. “These experiments, because of the lack of informed consent, violated the Nuremburg Code established just 10 years earlier,” says White-Lief.

Note: The extreme racism of the Nazis was quite popular among certain groups in the U.S. For lots more on how these ideas came to pervade some groups in U.S. intelligence services, click here. For a powerful list of military and government sponsored experiments on human guinea pigs with links for verification, click here.

Oops. That's the word that comes to mind when reading Michael Carroll's thoroughly nerve-wracking book, "Lab 257: The Disturbing Story of the Government's Secret Germ Laboratory" ... about the federal germ facility on Plum Island. The island [is] home to some of the deadliest microbes festering on the planet. According to Carroll's book, the island -- and laboratory -- are also home to slipshod construction, poor safeguards, and lax security. "Lab 257" claims errors at the facility caused Lyme disease outbreaks and health problems for the local population -- claims disputed by the U.S. Department of Agriculture, which ran the facility until recently. Carroll [said] that the point of the book was to expose the potential hazards of a poorly run institution; he has nothing against better-run, more secure institutions. "You have to know how things interact, germs, bacteria, etc. You [just] don't need to create millions of them to know how to create them and make them more virulent. Like other government scientific facilities, it's had an aura of mystery: Plum Island earns a mention in "The Silence of the Lambs," and thriller writer Nelson DeMille set a novel there. Much of Carroll's research was done through interviews with nearby residents, as well as documents and reports. While the government was "cooperative at the outset," Carroll said ... he was later denied access to the facility. Carroll isn't the first to offer criticism. In 2002, after a power outage on the island, New York's WABC-TV did a story on whether containment procedures worked; several employees questioned the lab's safety. In 2003, the General Accounting Office listed security problems on the island, partially prompted by a whistleblower, Jim McCoy, who protested the management of a private concern.

Note: At the northernmost tip of Long Island, Plum island sits directly across from the town of Lyme, Conn., famous as the epicenter of the Lyme disease outbreak. For a powerful, multiple award-winning film showing shocking ignorance and even political corruption on the part of the medical community about the Lyme disease epidemic spreading across the US and even around the world, click here. It shows evidence that Lyme may be even the cause of many cases of ALS, Parkinson's, and Alzheimer's disease.

Eight months have passed since the Department of Homeland Security took over the management of Plum Island from the Agriculture Department. Last week, Homeland Security officials offered a rare glimpse into this veiled and mysterious island. The timing of the tour for a dozen journalists coincided with the publication of a new book, ''Lab 257,'' by Michael Christopher Carroll, who argues that the Plum Island laboratories have an appalling safety record and can be linked to outbreaks of Lyme disease and West Nile virus. There have long been questions about the safety of Plum Island's operations, but they became more prevalent after the Sept. 11 terrorist attacks. Mr. Carroll, a lawyer from Bellmore, writes that in 2002 American forces in Afghanistan found a file on the Plum Island laboratory in the home of a nuclear physicist identified by American officials as an associate of Osama bin Laden. Mr. Carroll, who calls the lab a ticking biological time bomb, describes low employee morale and a decline in security after a private company took over support functions in 1991. A report from the General Accounting Office released in October also criticized security at the center, saying that officials did not control access to dangerous pathogens that could be adapted for germ warfare. The report also cited door alarms and sensors that did not work ... and insufficient background checks. Plum Island and Homeland Security officials said there have been no direct terrorist threats against the lab, which studies foot-and-mouth disease and swine fever, among other diseases.

Note: At the northernmost tip of Long Island, Plum island sits directly across from the town of Lyme, Conn., famous as the epicenter of the Lyme disease outbreak. For a powerful, multiple award-winning film showing shocking ignorance and even political corruption on the part of the medical community about the Lyme disease epidemic spreading across the US and even around the world, click here. It shows evidence that Lyme may be even the cause of many cases of ALS, Parkinson's, and Alzheimer's disease.

Generic drugs are just as safe and effective as their brand-name counterparts but they cost only a fraction as much. That is because companies that produce the generic versions simply copy the formula developed by the drug’s inventor years before. While your drugstore charges you less for a generic drug than a brand name version, that price difference is nothing compared to the markup most druggists place on the generics. Your pharmacy most likely paid a wholesale price of only pennies for that generic medicine. They then charge you a markup of 3,000%, 4,000%, even 5,000% or more, pocketing most of your savings. Who’s paying sky-high prices? People who can least afford to get ripped off—the elderly, the unemployed, and everybody who has to pay for their prescription medicine out of their own pocket. At CVS the cost of generic Prozac is marked up at least 56 times what the drug cost wholesale. It is a 5,594% markup. And in our survey of more than a dozen popular generic drugs, CVS leads the pack with average markups of 1,436% Walgreen’s is not far behind at 1,341% and Rite Aid markups on generics average 1,183%. [WXYZ reporter] Steve Wilson took the issue to Kurt Proctor, Vice President of the Association of Chain Drug Stores. "Explain to me why it’s necessary to take an 82 cent product and mark it up to $46.69? You have to mark it up 5,500% to meet your costs to make a profit? This is really about greed, isn’t it?" asked Wilson. "It’s not about greed," responded Proctor. "That’s not accurate at all. That’s a misleading statement. What I hope you will focus on is making sure people use their medications correctly."

Note: This important exposure of price-gouging by pharmacies is still available at Web Archive (click on the link above for the complete article, which is well worth reading in its entirety), but for some reason has been taken down at WXYZ's website. Could it be someone doesn't want us to know about this?

Between 1999 and 2001, unbeknownst to the others, each [of four scientists] made a simple but dramatic discovery that challenged the catechism of the same powerful industry -- biotechnology -- that by then had become the handmaiden of industrial agriculture and the darling of venture capitalists. When he was the principal scientific officer of the Rowett Institute in Aberdeen, Scotland, Hungarian citizen Arpad Pusztai fed transgenically modified [GMO] potatoes to rodents in one of the few experiments that have ever tested the safety of genetically modified food. Almost immediately, the rats displayed tissue and immunological damage. After he reported his findings, which eventually underwent peer review and were published in the United Kingdom's leading medical journal, Lancet, Pusztai's home was burglarized and his research files taken. Soon thereafter, he was fired from his job at Rowett, and he has since suffered an orchestrated international campaign of discreditation. [Read full article for the other three distrubing stories of scientific suppression] These four men were not attacked because of flawed or imperfect experiments but because the findings of their work have a potential economic effect. The sad part is that the academies and other allegedly independent institutions that once defended scientific freedom and protected employees like Hayes, Chapela, Losey and Pusztai are abandoning them to the wolves of commerce, the brands of which are being engraved over the entrances to a disturbing number of university labs.

Note: Big money is clearly stifling good science and keeping the public in the dark about genetic modifications in the food we eat. To educate yourself on this most important topic, click here.

Researchers at an Australian university believe they have developed a breakthrough showing skin cancer can be stopped by the common cold virus. Skin cancer, or melanoma, is the fifth most common form of cancer. Australia has the highest rate of melanoma in the world, with one out of every two people likely to develop some form of the disease during their lifetime. A team led by Professor Darren Shafren at the University of Newcastle, about 150 kilometers north of Sydney, have established that malignant melanoma cells can be destroyed by infecting them with coxsackievirus, the common cold virus. "We believe this is a significant breakthrough in the development of the treatment of melanoma," Dr Shafren said in a statement released by the university Wednesday. He said the results achieved so far using human cells and in animal studies had been "very exciting". "If we can replicate that success in human trials, the treatment of this often fatal disease could be available within the next few years," he said. According to the university researchers, the projected process begins by injecting the common cold virus into a melanoma. The virus replicates itself and then, according to the projection, begins killing off the melanoma. Within weeks, there is a reduction in the size of the melanoma and it eventually disappears. Dr Shafren noted that the coxsackievirus was not a manufactured drug or a genetically altered virus. Instead, it was a virus that occurred in the community.

Note: Why wasn't this exciting development put on the fast track and lots of money pored in to develop it quickly. Could it be that this cancer treatment would negatively impact the huge profits of the drug companies? For more reliable information on this, click here.

Hundreds of articles in medical journals claiming to be written by academics or doctors have been penned by ghostwriters in the pay of drug companies, an Observer inquiry reveals. The journals, bibles of the profession, have huge influence on which drugs doctors prescribe and the treatment hospitals provide. But The Observer has uncovered evidence that many articles written by so-called independent academics may have been penned by writers working for agencies which receive huge sums from drug companies to plug their products. Estimates suggest that almost half of all articles published in journals are by ghostwriters. While doctors who have put their names to the papers can be paid handsomely for 'lending' their reputations, the ghostwriters remain hidden. In the United States a legal case brought against drug firm Pfizer turned up internal company documents showing that it employed a New York medical writing agency. One document analyses articles about the anti-depressant Zoloft. Some of the articles lacked only one thing: a doctor's name. In the margin the agency had put the initials TBD, which Healy assumes means 'to be determined'. Dr Richard Smith, editor of the British Journal of Medicine, admitted ghostwriting was a 'very big problem'. 'We are being hoodwinked by the drug companies. The articles come in with doctors' names on them and we often find some of them have little or no idea about what they have written,' he said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science from reliable major media sources.

A research team backed by a federal grant has created a genetically engineered mousepox virus designed to evade vaccines, underscoring biotechnology's deadly potential and stirring debate over whether such research plays into the hands of terrorists. The team at Saint Louis University, led by Mark Buller, created the superbug to figure out how to defeat it. Buller spliced a gene known to suppress the immune system into the mousepox virus, then injected the combined strand into vaccinated mice. All of them died. The research highlights a contentious discussion among scientists and security experts: Does publication of such work help or hinder the biodefense effort? Should such studies be conducted at all? When Buller presented his results last week at an international biodefense conference, it prompted debate. Some feared that publication of such information, regardless of whether scientists' intentions are altruistic, could help terrorists create biological weapons laced with genetically modified superbugs. Such germs are created by splicing drug-resistant genes in viruses normally defeated by vaccines. Alibek, a director of George Mason University's National Center for Biodefense, believes Buller's work and similar research should be confidential to impede terrorists and rogue nations from acquiring knowledge about genetically engineered bioweapons. Buller counters that publicizing such work will deter terrorists by showing that scientists can build defenses against souped-up bioweapons. Buller also believes scientists must genetically engineer pathogens to understand how to defeat them.

Edward McSweegan ... has an office in Bethesda, a job title -- health scientist administrator -- and an annual salary of about $100,000. What McSweegan says he does not have -- and has not had for the last seven years -- is any real work. He was hired by the National Institute of Allergy and Infectious Diseases in 1988, but says his bosses transferred the research grants he administered to other workers eight years later, leaving him with occasional tasks more suitable for a typist or "gofer." McSweegan used to be NIH's program officer for Lyme disease but was removed from the post in June 1995 after a dispute over his repeated criticism of a politically influential support group for sufferers and his allegations that NIH had been too accommodating of the group. He had publicly described the Lyme Disease Foundation as "wacko" because he disagreed with its theories about the disease. The dispute led to his suspension without pay for two weeks for insubordination. According to NIH, McSweegan is director of the U.S.-Indo Vaccine Action Program, and has traveled to countries such as Russia representing the agency. He has also "produced reports and other work products." But McSweegan said he has never been told he was director of the program. McSweegan said he struggles to fill his eight-hour workdays by reading, exercising and writing fiction. He has self-published a bioterrorism thriller and a science fiction novel. But he says his six-page job description is the ultimate work of creative writing and describes his position as "a bizarre, surreal situation -- part Orwell, part Kafka and part Dilbert."

A division of the pharmaceutical company Bayer sold millions of dollars of blood-clotting medicine for hemophiliacs -- medicine that carried a high risk of transmitting AIDS -- to Asia and Latin America in the mid-1980's while selling a new, safer product in the West. The Bayer unit, Cutter Biological, introduced its safer medicine in late February 1984 as evidence mounted that the earlier version was infecting hemophiliacs with H.I.V. Yet for over a year, the company continued to sell the old medicine overseas. Cutter officials were trying to avoid being stuck with large stores of a product. Yet even after it began selling the new product, the company kept making the old medicine for several months more. In Hong Kong and Taiwan alone, more than 100 hemophiliacs got H.I.V. after using Cutter's old medicine. Many have since died. Cutter also continued to sell the older product after February 1984 in Malaysia, Singapore, Indonesia, Japan and Argentina. While admitting no wrongdoing, Bayer and three other companies that made the concentrate have paid hemophiliacs about $600 million to settle more than 15 years of lawsuits accusing them of making a dangerous product. Federal regulators helped keep the overseas sales out of the public eye. The Food and Drug Administration's regulator of blood products, Dr. Harry M. Meyer Jr....asked that the issue be "quietly solved without alerting the Congress, the medical community and the public."

The number of kids in California being treated for autism doubled between 1998 and 2002, and there is still no end in sight to the growing trend, state officials reported. The report ... found that 10,360 autistic children sought services in 1998. By the end of last year the number had jumped to 20,377, a 97 percent increase, far outstripping the growth rate in population or births. Concern over rising autism rates has been growing since the late 1990s as parents, educators and pediatricians began reporting increasing numbers of affected children across the country. As many as 20 different genes are known to play a role, but it also is believed that environmental factors are at work. Steep increases have also been documented in other industrialized countries such as Japan and Israel. "California is absolutely not special," Huff said. "In fact, we're middle of the road in terms of our rates." Scientists continue to search for a cause. Theories abound, including the possibility that childhood immunizations may be involved. However, recent studies into the measles, mumps and rubella (MMR) vaccine have not shown a link. Others have suggested that environmental toxins or food additives might be the cause. Some research has focused on possible causes in the womb, including a mother's immune response to common infections that could affect the developing fetus. Researchers connected to the MIND Institute found in an initial study that high levels of certain proteins in the blood of newborns could predict which ones went on to develop autism and mental retardation.

Note: Though industry-funded studies have shown no link between autism and vaccines, there is plenty of evidence to the contrary. For reliable information on this key topic, click here.

It's been a mystery in Washington for weeks. Just before President Bush signed the homeland security bill into law an unknown member of Congress inserted a provision into the legislation that blocks lawsuits against the maker of a controversial vaccine preservative called "thimerosal," used in vaccines that are given to children. Drug giant Eli Lilly and Company makes thimerosal. It's the mercury in the preservative that many parents say causes autism in thousands of children. But nobody in Congress would admit to adding the provision, reports CBS News Correspondent Jim Acosta – until now. House Majority Leader Dick Armey tells CBS News he did it to keep vaccine-makers from going out of business under the weight of mounting lawsuits. "I did it and I'm proud of it," says Armey, R-Texas. "It's a matter of national security," Armey says. Because Armey is retiring at the end of the year, some say the outgoing majority leader is the perfect fall guy to take the heat and shield the White House from embarrassment.

Note: A Reuters article reports that the former head of the US's CDC was later named president of Merck's vaccine division with accompanying high salary. Could this be payoff for her support in suppressing studies that cast doubt on vaccines?

British drug giant GlaxoSmithKline has finally admitted that thousands of babies in this country were inoculated with a batch of toxic whooping cough vaccines in the 1970s. Some experts believe that these Trivax vaccines - which had not passed critical company safety tests - may have caused permanent brain damage and even fatalities in young children. In 1992, the family of an Irish boy, Kenneth Best, who suffered brain damage from one of these toxic vaccines, was awarded Ł2.7 million in compensation by the Irish Supreme Court. The boy's family finally won this historic case after his mother Margaret made a startling find when sifting through tens of thousands of company documents. She discovered that the Trivax vaccine used on her son, from a batch numbered 3,741, had been released by the company despite it having failed to pass a critical safety test. Documents revealed that the 60,000 individual doses within this batch were known to be 14 times more potent than normal. Last year an investigation by The Observer found evidence to suggest that vaccines from this faulty batch ... had also been used in Britain. Liberal Democrat MP Norman Baker raised questions in the House of Commons, asking whether vaccines from this batch had been given to British babies. Then Health Minister Yvette Cooper wrote to the company asking for information. Now, almost a year later, GlaxoSmithKline has replied that it is 'highly probable' the toxic batches had been used in Britain.

Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccine risks from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

The Ministry of Defence turned large parts of the country into a giant laboratory to conduct a series of secret germ warfare tests on the public. A government report just released provides for the first time a comprehensive official history of Britain's biological weapons trials between 1940 and 1979. Many of these tests involved releasing potentially dangerous chemicals and micro-organisms over vast swaths of the population without the public being told. While details of some secret trials have emerged in recent years, the 60-page report reveals new information about more than 100 covert experiments. The report reveals that military personnel were briefed to tell any 'inquisitive inquirer' the trials were part of research projects into weather and air pollution. The tests [were] carried out by government scientists at Porton Down. In most cases, the trials did not use biological weapons but alternatives which scientists believed would mimic germ warfare and which the MoD claimed were harmless. But families in certain areas of the country who have children with birth defects are demanding a public inquiry.

Note: Military personnel were ordered to lie to cover-up potentially dangerous experiments on the public. So how can we trust that these people have the public interest as a priority?

A monkey virus found in early versions of a vaccine against polio may be linked to a common type of cancer, suggest scientists. Batches of polio vaccine tainted with "simian virus 40" (SV40) were given between 1955 and 1963. This was because monkey kidney cells were used in the [vaccine's] production process. It is [now] conceded that SV40 was present in the early vaccine - and the latest research, published in the Lancet journal, has linked it to non-Hodgkin's lymphoma. This is a cancer of the lymphatic system, which has a role in the body's fight against infection, and affects mainly the over 40s. The researchers looked at hundreds of tumours taken from various cancer patients, and compared them with 68 samples taken from non-Hodgkin's patients. They found genetic "footprints" of the virus in 43% of the non-Hodgkin's tumour cells.

Note: This information was uncovered years ago by Merck's top vaccine expert, Maurice Hilleman, who acknowledged that he unintentionally imported the AIDS virus to the US. See the shocking video of his testimony available here (text here). For lots of reliable information raising serious questions about the dangers of vaccines, click here and here.

With safety concerns widespread, Americans almost unanimously favor mandatory labels on genetically modified foods. And most say they'd use those labels to avoid the food. Barely more than a third of the public believes that genetically modified foods are safe to eat. Instead 52 percent believe such foods are unsafe, and an additional 13 percent are unsure about them. That's broad doubt on the very basic issue of food safety. Nearly everyone, moreover — 93 percent — says the federal government should require labels on food saying whether it's been genetically modified, or "bio-engineered" (this poll used both phrases). Such near-unanimity in public opinion is rare. Fifty-seven percent also say they'd be less likely to buy foods labeled as genetically modified. The image problem of genetically modified food is underscored by contrast to organic foods. While only five percent of Americans say they'd be more likely to buy a food labeled as genetically modified, 52 percent say they'd be more likely to buy food that's labeled as having been raised organically. Genetically modified foods are particularly unpopular among women, another problem for food producers since so many women do the family shopping. Sixty-two percent of women think genetically modified foods are unsafe to eat, a view that's shared by far fewer men, 40 percent.

Note: Members of the U.S. Congress are finally starting to take action on this most important topic. For more key information on what you can do to help, click here.

Last fall, at a business lunch with co-workers, Grace Booth enjoyed three chicken enchiladas. The food, she recalls, was very good — but then something went very wrong. "I thought, oh my God, what is happening to me? I felt like I was going to die." In the emergency room in nearby Oakland the diagnosis was severe allergic reaction and from here Grace Booth's story reached officials in Washington. At the time the national corn market was in an uproar. Starlink, a gene modified corn not approved for human food, had been found in taco shells and recalls were emptying the shelves of corn products. The fear was possible allergic reactions. At that moment, Booth says, she had no idea that the corn tortillas in her lunch were about to be recalled. In the wake of the recalls more than 50 Americans, including Booth, claimed they had reactions to Starlink corn. That forced the government to launch the first full-scale allergy investigation in the history of biotech food. It has taken months, but the Centers for Disease Control and the Food and Drug Administration have collected food samples and blood from two dozen people whose cases were believed most serious. [Symptoms] "[v]aried from just abdominal pain and diarrhea [or] skin rashes to some patients ... having very severe life-threatening reactions," said Dr. Marc Rothenberg, the allergy chief at Cincinnati Children's Hospital. He is an adviser to the government in the Starlink investigation. Its slow going he says because investigators first had to find the Starlink protein and then invent a blood test.

Note: The date of this article is May 17, 2001, though on the webpage itself a different date is listed. With so many examples of allergic reactions and more to GM foods, why does the FDA continue to insist that these foods are safe? Could it be because many top leaders at the FDA once worked at Monsanto?

Two days after agreeing to pay states nearly $20 million for falsely marketing OxyContin, the drug's maker, Perdue Pharma, and three current and former executives plead guilty to federal charges. The Stamford, Conn.-based maker of the powerful painkiller, and three of its current and former executives, pleaded guilty Thursday to misleading the public about OxyContin's risk of addiction. Purdue Pharma L.P., its president, top lawyer and former chief medical officer will pay $634.5 million in fines for claiming the drug was less addictive and less subject to abuse than other pain medications, U.S. Attorney John Brownlee said. The plea agreement comes after the company agreed to pay $19.5 million to 26 states and the District of Columbia to settle complaints that it encouraged physicians to overprescribe OxyContin. Even though the company was warned by health professionals, the media and members of its own sales force, "Perdue continued to push a fraudulent marketing campaign that promoted OxyContin as less addictive, less subject to abuse and less likely to cause withdrawal when they knew in fact that that was not true," Brownlee told CBS News correspondent Barry Bagnato. "Doctors are often approached right in their offices by pharmaceutical company sales reps dispensing information about one medication or another," said CBS News medical correspondent Dr. Jon LaPook. "This case is a reminder to doctors not to believe everything they hear."

Note: The family which owns Purdue, maker of OxyContin, is among the 20 richest families in the U.S., thanks largely to sales of Oxycontin, which has resulted in thousands of overdose deaths, according to this article in Forbes. For more, see this revealing article. Then see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and health.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.